ResearcherBeijing University of Chinese MedicineNo recent work listed
Haojia Wang
Matched on ORCID iD 0000-0002-1457-8458; OpenAlex author ID A5084395959. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2022: 1 paper · 2023: 1 paper
Papers 2
- Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in … Co-author DOI 10.1186/s13020-023-00710-2↗
- A novel strategy to reveal clinical advantages and molecular mechanism of aidi injection in the treatment of pancreatic cancer based on network meta-analysis a… Co-author DOI 10.1016/j.jep.2021.114852↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jiarui Wu · 2 shared papers, 2022–2023 · strength 0.29
- Paper Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer b… DOI 10.1186/s13020-023-00710-2↗
- Paper A novel strategy to reveal clinical advantages and molecular mechanism of aidi injection in the treatment of pancreatic… DOI 10.1016/j.jep.2021.114852↗
- Chao Wu · 2 shared papers, 2022–2023 · strength 0.29
- Paper Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer b… DOI 10.1186/s13020-023-00710-2↗
- Paper A novel strategy to reveal clinical advantages and molecular mechanism of aidi injection in the treatment of pancreatic… DOI 10.1016/j.jep.2021.114852↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.